Skip to main content
Clinical Trials/ACTRN12624000743561
ACTRN12624000743561
Not yet recruiting
未知

In people with nociceptive or neuropathic dominant chronic low back pain, is multi-disciplinary pain management plus motor control training individualised for the spine (MInS) more effective than multi-disciplinary pain management alone for improving activity limitation

a Trobe University0 sites184 target enrollmentJune 14, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic low back pain with predominant features of nociceptive or neuropathic pain
Sponsor
a Trobe University
Enrollment
184
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
a Trobe University

Eligibility Criteria

Inclusion Criteria

  • i. Have a primary complaint of chronic low back pain (pain of greater than 3 months duration)
  • ii.Referred for a multidisciplinary pain management program
  • iii.Aged between 18 and 60 years
  • iv.Sufficient fluency in English to complete all baseline and follow up questionnaires
  • v.Are presumed to have a pain type of nociceptive or neuropathic dominant based on established criteria

Exclusion Criteria

  • i.Red flag pathologies (active cancer, signs of cauda equina syndrome based on bladder or bowel disturbance, risk of spinal fracture, signs of potential infection, systemic inflammatory disease.
  • ii.Active cancer, pelvic pain or neuropathic pain not related to low back disorders
  • iii.Recent or pending surgery for the pain condition;
  • iv.Pregnancy or childbirth within the last 6 months
  • v.Spinal injections for the pain problem within the last 6 weeks
  • vi.Already received multi\-disciplinary pain management for the pain problem within the last 2 years, to avoid contamination
  • vii.Unable to participate in a pain management program to improve lumbar spine related activity limitation, due to significant musculoskeletal comorbidity

Outcomes

Primary Outcomes

Not specified

Similar Trials